Lexeo Therapeutics, Inc. (LXEO) Operating income 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual operating income history from SEC filings — each fiscal year as reported.
-$109.3MFY2025 · since FY2022: -$60.5M → -$109.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$109.3M | -3.3% |
| FY2024 | -$105.8M | -54.4% |
| FY2023 | -$68.5M | -13.2% |
| FY2022 | -$60.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice